Exp Mol Med
From Bioblast
| Journal title and website | Experimental & Molecular Medicine |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Kankuri 2023 Exp Mol Med | Kankuri E, Finckenberg P, Leinonen J, Tarkia M, Björk S, Purhonen J, Kallijärvi J, Kankainen M, Soliymani R, Lalowski M, Mervaala E (2023) Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity. https://doi.org/10.1038/s12276-023-00967-5 | 2023 | Exp Mol Med 55:806-17. PMID: 37009793 Open Access |
| Scheiber 2019 Exp Mol Med | Scheiber D, Jelenik T, Zweck E, Horn P, Schultheiss HP, Lassner D, Boeken U, Saeed D, Kelm M, Roden M, Westenfeld R, Szendroedi J (2019) High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure. Exp Mol Med 51:16. | 2019 | PMID: 30765687 Open Access |
| Kang 2018 Exp Mol Med | Kang YC, Son M, Kang S, Im S, Piao Y, Lim KS, Song MY, Park KS, Kim YH, Pak YK (2018) Cell-penetrating artificial mitochondria-targeting peptide-conjugated metallothionein 1A alleviates mitochondrial damage in Parkinson's disease models. Exp Mol Med 50:105. | 2018 | PMID: 30120245 Open Access |
| Jeong 2017 Exp Mol Med | Jeong JH, Cheol Kang Y, Piao Y, Kang S, Pak YK (2017) miR-24-mediated knockdown of H2AX damages mitochondria and the insulin signaling pathway. Exp Mol Med 49:e313. | 2017 | PMID: 28386126 Open Access |
| Rhee 1999 Exp Mol Med | Rhee SG (1999) Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31:53-9. | 1999 | PMID:10410302 |
